{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions dx"],"components":["Active, inactive dw"],"effective_time":"20190509","id":"887a6d0f-d339-48b9-e053-2a95a90af2a0","instructions_for_use":["Directions for use de"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1064-2 DAPSONE USP 8.5% / NIACINAMIDE USP 2% / SPIRONOLACTONE USP 5%. Gel 30gm a"],"set_id":"887a6d0f-d338-48b9-e053-2a95a90af2a0","spl_product_data_elements":["DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5% SPIRONOLACTONE SPIRONOLACTONE DAPSONE DAPSONE NIACINAMIDE NIACINAMIDE"],"version":"1"}